AMH and Infertility: In the ADAPT-1 trial, participants had an overall mean age of 34.5 years, a baseline mean bodyweight of 66.4 and 67.5 kg, mean antral follicle count of 13.3 and 13.8, and serum AMH mean of 14.5 and 15.2 pmol/l for the follitropin delta and follitropin alfa groups, respectively, reflecting real-world infertile patients at specialist reproductive health clinics for whom clinicians would likely treat with a starting dose of follitropin alfa 225 IU.